Rick Panton, Principal Engineer, Global Engineering – Drug Product from Roche pharmaceuticals outlines “the potential of Enzyme Indicators to revolutionise how we measure and monitor our VPHP decontamination practices is transformative”
Our journey started with these questions:
How can we increase our system knowledge and reduce risk in our VPHP process?
We needed a way to better measure the local peroxide environment
How can we increase our operational production uptime on our drug product filling systems?
We wanted to better optimize VPHP deconcycles to maximize production time on filling systems
How can we reduce risk of requalification deviations and improve accuracy in finding true root cause?
Requalification of VPHP decontamination cycles comes with risk, not always of system error/malfunction, but variability in BI’s, and possible lab error
Please complete the form below to receive a copy of the full Case Study.
